Contact lens surveillance cultures in boston type 1 keratoprosthesis patients

Eye and Contact Lens

Volumn 39, Issue 2, 2013, Pages 175-178

  Rai, Ruju ^a   Shorter, Ellen ^a   Cortina, Maria S ^a   McMahon, Timothy ^a   Cruz, Jose De La ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; AUTOIMMUNE DISEASE; BACTERIAL COLONIZATION; BACTERIUM CULTURE; BANDAGE CONTACT LENS; CHEMICAL BURN; CHILD; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; ENDOPHTHALMITIS; FEMALE; HUMAN; KERATOPROSTHESIS; MALE; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SCHOOL CHILD; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFECTIVE AGENTS; ARTIFICIAL ORGANS; CHILD; CONTACT LENSES; CORNEA; CORNEAL DISEASES; EYE INFECTIONS, BACTERIAL; EYE INFECTIONS, FUNGAL; FEMALE; HUMANS; KERATITIS; MALE; MIDDLE AGED; PROSTHESIS IMPLANTATION; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84874948705     PISSN: 15422321     EISSN: 1542233X     Source Type: Journal    
DOI: 10.1097/ICL.0b013e31827aff8f     Document Type: Review

References (22)

1. Ament JD, Stryjewski TP, Ciolino JB, et al. Cost-effectiveness of the Boston keratoprosthesis. Am J Ophthalmol 2010;149:221-228.
2. Traish AS, Chodosh J. Expanding application of the Boston Type 1 keratoprosthesis due to advances in design and improved post-operative therapeutic strategies. Semin Ophthalmol 2010;25:239-243.
3. Ramchandran RS, Diloreto DA Jr, Chung MM, et al. Infectious endophthalmitis in adult eyes receiving Boston type 1 keratoprosthesis. Ophthalmology 2012;119:674-681.
4. Cardona H, DeVoe AG. Prosthokeratoplasty. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977;83:271-280.
5. Khan BF, Harissi-Dagher M, Khan DM, et al. Advances in Boston keratoprosthesis: enhancing retention and prevention of infection and inflammation. Int Ophthalmol Clin 2007;47:61-71.
6. Szczotka-Flynn LB, Pearlman E, Ghannoum M. Microbial contamination of contact lenses, lens care solutions, and their accessories: a literature review. Eye Contact Lens 2010;36:116-129.
7. Das S, Sheorey H, Taylor HR, et al. Association between cultures of contact lens and corneal scraping in contact lens related microbial keratitis. Arch Ophthalmol 2007;125:1182-1185.
8. Aldave AJ, Kamal KM, Vo RC, et al. The Boston type 1 keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116: 640-651.
9. Aquavella JV, Qian Y, McCormick GJ, et al. Keratoprosthesis: the Dohlman-Doane device. Am J Ophthalmol 2005;140:1032-1038.
10. Bradley JC, Hernandez EG, Schwab IR, et al. Boston type 1 keratoprosthesis: the university of California Davis experience. Cornea 2009;28: 321-327.
11. Chew HF, Ayres BD, Hammersmith KM, et al. Boston keratoprosthesis outcomes and complications. Cornea 2009;28:989-996.
12. Fintelmann RE, Maguire JI, Ho AC, et al. Characteristics of endophthalmitis in patients with the Boston keratoprosthesis. Cornea 2009;28:877-878.
13. Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001; 119:484-489.
14. Zerbe BL, Belin MW, Ciolino JB. Boston type 1 keratoprosthesis study group. Results from the multicenter Boston type 1 keratoprosthesis study. Ophthalmology 2006;113:1779.e1-1779.e7.
15. Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009;28:896-901.
16. Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 2012;31:346-349.
17. Graham JE, Moore JE, Jiru X, et al. Ocular pathogen or commensal: A PCR-based study of surface bacterial flora in normal and dry eyes. Invest Ophthalmol Vis Sci 2007;48:5616-5623.
18. Alexandrakis G, Alfonso EC, Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 2000;107:1497-1502.
19. Scoper SV. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy. Adv Ther 2008;25:979-994; review.
20. Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea 2007; 26:9-15.
21. Keating A, Pineda R 2nd. Trichosporon asahii keratitis in a patient with a type 1 Boston keratoprosthesis and contact lens. Eye Contact Lens 2011; 38:130-132.
22. Tang CW, Cheng CK, Lee TS. Community-acquired bleb-related endophthalmitis caused by vancomycin-resistant enterococci. Can J Ophthalmol 2007;42:477-478.